ES2058543T3 - Dispositivo de liberacion controlada con un revestimiento impermeable que tiene un orificio para la liberacion de farmaco. - Google Patents

Dispositivo de liberacion controlada con un revestimiento impermeable que tiene un orificio para la liberacion de farmaco.

Info

Publication number
ES2058543T3
ES2058543T3 ES89308645T ES89308645T ES2058543T3 ES 2058543 T3 ES2058543 T3 ES 2058543T3 ES 89308645 T ES89308645 T ES 89308645T ES 89308645 T ES89308645 T ES 89308645T ES 2058543 T3 ES2058543 T3 ES 2058543T3
Authority
ES
Spain
Prior art keywords
hole
controlled release
pharmacy
release
waterproof coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89308645T
Other languages
English (en)
Inventor
John Nicholas Staniforth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Forum Chemicals Ltd
Coordinated Drug Development Ltd
Original Assignee
Forum Chemicals Ltd
Coordinated Drug Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forum Chemicals Ltd, Coordinated Drug Development Ltd filed Critical Forum Chemicals Ltd
Application granted granted Critical
Publication of ES2058543T3 publication Critical patent/ES2058543T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Coating Apparatus (AREA)
  • Paints Or Removers (AREA)

Abstract

DISPOSITIVOS DE LIBERACION CONTROLADA TENIENDO UN NUCLEO INCLUYENDO UN AGENTE ACTIVO Y OTRA CUBIERTA LA CUAL ES SUSTANCIALMENTE IMPERMEABLE CONTRA LA ENTRADA DE UN FLUIDO AMBIENTAL Y SUSTANCIALMENTE IMPERMEABLE PARA LA LIBERACION DE UN AGENTE ACTIVO DURANTE UN PERIODO DE DESPACHO PERMITEN LA LIBERACION CONTROLADA DEL AGENTE ACTIVO A TRAVES DE UN ORIFICIO EN LA CUBIERTA MAS EXTERNA.
ES89308645T 1988-08-26 1989-08-25 Dispositivo de liberacion controlada con un revestimiento impermeable que tiene un orificio para la liberacion de farmaco. Expired - Lifetime ES2058543T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888820353A GB8820353D0 (en) 1988-08-26 1988-08-26 Controlled release tablet

Publications (1)

Publication Number Publication Date
ES2058543T3 true ES2058543T3 (es) 1994-11-01

Family

ID=10642806

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89308645T Expired - Lifetime ES2058543T3 (es) 1988-08-26 1989-08-25 Dispositivo de liberacion controlada con un revestimiento impermeable que tiene un orificio para la liberacion de farmaco.

Country Status (10)

Country Link
US (1) US5004614A (es)
EP (1) EP0365123B1 (es)
AT (1) ATE110262T1 (es)
AU (1) AU4218489A (es)
CA (1) CA1339079C (es)
DE (1) DE68917677T2 (es)
ES (1) ES2058543T3 (es)
GB (2) GB8820353D0 (es)
IE (1) IE63764B1 (es)
WO (1) WO1990001925A1 (es)

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366738A (en) * 1982-07-29 1994-11-22 Merck & Co., Inc. Controlled release drug dispersion delivery device
US5178866A (en) * 1990-03-23 1993-01-12 Alza Corporation Dosage form for delivering drug to the intestine
JPH11508224A (ja) * 1990-08-09 1999-07-21 エンドコン・インコーポレーテッド 多重ドラッグデリバリーシステム
AU651654B2 (en) * 1992-01-14 1994-07-28 Endo Pharmaceuticals Solutions Inc. Manufacture of water-swellable hydrophilic articles and drug delivery devices
US5266325A (en) * 1990-09-28 1993-11-30 Hydro Med Science Division Of National Patent Development Corp. Preparation of homogeneous hydrogel copolymers
DK0551292T3 (da) * 1990-10-01 1995-11-27 Upjohn Co Farmaceutiske præparater til reguleret frigivelse med overtrukken sidekant
US5922342A (en) * 1990-10-01 1999-07-13 Pharmacia & Upjohn Company Lateral edge coated controlled release pharmaceutical compositions
AU657514B2 (en) * 1991-01-03 1995-03-16 Glaxo Canada Inc. Method for production of solid pharmaceutical preparation
US5543154A (en) * 1991-12-27 1996-08-06 Merck & Co., Inc. Controlled release nifedipine delivery device
WO1993022915A1 (en) * 1992-05-12 1993-11-25 Church & Dwight Company, Inc. Insecticide compositions
AU3801793A (en) * 1992-05-12 1993-12-13 Church & Dwight Company, Inc. Herbicide compositions
AU3917393A (en) * 1992-05-12 1993-12-13 Church & Dwight Company, Inc. Fungicide compositions
DK0636551T3 (da) * 1993-07-12 1996-08-26 Nestle Sa Beholderlukke med sikkerhedsring
DE4431653C2 (de) * 1994-09-06 2000-01-20 Lohmann Therapie Syst Lts Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
US6342570B1 (en) * 1994-11-14 2002-01-29 Novartis Ag Cross-linkable copolymers and hydrogels
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
US5830884A (en) * 1995-01-18 1998-11-03 National Starch And Chemical Investment Holding Corporation Pharmaceutical products containing thermally-inhibited starches
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US20060280774A1 (en) * 1995-06-02 2006-12-14 Allergan, Inc. Compositions and methods for treating glaucoma
US5733270A (en) * 1995-06-07 1998-03-31 Baxter International Inc. Method and device for precise release of an antimicrobial agent
ATE286394T1 (de) * 1995-09-21 2005-01-15 Pharma Pass Ii Llc Ein säurelabile omeprazol enthaltende arzneizusammensetzung und verfahren zu deren herstellung
US6361796B1 (en) * 1996-10-25 2002-03-26 Shire Laboratories, Inc. Soluble form osmotic dose delivery system
DE19728249C2 (de) * 1997-07-02 2001-05-03 Georgios Pandalis Produkt aus einem Kern und mindestens einer ein Naturharz enthaltenden Umhüllung, Steckkapsel, Verfahren zur Herstellung einer Filmtablette, Weichkapsel, Steckkapsel und Verwendung von Naturharzen
US6110500A (en) * 1998-03-25 2000-08-29 Temple University Coated tablet with long term parabolic and zero-order release kinetics
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
US6331313B1 (en) 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US6497157B1 (en) * 1999-11-29 2002-12-24 Distek, Inc. Intrinsic dissolution apparatus with stationary sample holder
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
US6569152B2 (en) 2000-03-21 2003-05-27 Farrington Pharmaceuticals, Llc Sustained release delivery systems for solutes
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
GB0027471D0 (en) * 2000-11-08 2000-12-27 Smithkline Beecham Plc Processes
EP1339438B1 (en) 2000-11-29 2005-10-19 Allergan Inc. Preventing transplant rejection in the eye
US6544557B2 (en) * 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions
JP2005515966A (ja) * 2001-07-06 2005-06-02 エンドー ファーマシューティカルズ， インコーポレイティド 鎮痛薬としての使用のための６−ヒドロキシ−オキシモルホンの経口投与
AU2002317466B2 (en) * 2001-07-12 2008-02-28 Given Imaging Ltd Device and method for examining a body lumen
GB0117618D0 (en) * 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form
GB0120835D0 (en) 2001-08-28 2001-10-17 Smithkline Beecham Plc Process
US7850758B2 (en) * 2006-01-17 2010-12-14 The Andersons, Inc. Safened insecticide matter
NZ532096A (en) * 2001-09-28 2006-10-27 Mcneil Ppc Inc Dosage forms having an inner core and outer shell with different shapes
US20040253312A1 (en) * 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
PE20030800A1 (es) * 2002-02-12 2003-10-31 Glaxo Group Ltd Forma de dosificacion oral de liberacion controlada
KR101173497B1 (ko) * 2002-03-11 2012-08-14 알콘, 인코퍼레이티드 이식 가능한 약물 전달 시스템
US8637512B2 (en) * 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
EP1524981B1 (en) * 2002-07-29 2009-03-11 Glaxo Group Limited Sustained release formulations comprising lamotrigine
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US7037521B2 (en) * 2003-03-28 2006-05-02 Bausch & Lomb Incorporated Using a laser for cutting a hole in a capsule for controlled drug delivery
US20070148229A1 (en) * 2003-04-24 2007-06-28 Jagotec Ag Tablet with coloured core
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
PE20050335A1 (es) * 2003-08-07 2005-06-01 Sb Pharmco Inc Forma de dosificacion oral que comprende 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona y procedimiento para la preparacion
GB0318824D0 (en) * 2003-08-11 2003-09-10 Glaxo Group Ltd Novel composition
CA2547137A1 (en) * 2003-11-25 2005-06-09 Sb Pharmco Puerto Rico Inc. Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
EP1686967A4 (en) * 2003-11-25 2012-08-08 Smithkline Beecham Cork Ltd CARVEDILOL-FREE BASE, SALTS, WATER-FREE FORMS OR SOLVATES THEREOF, CORRESPONDING PHARMACEUTICAL COMPOSITIONS, CONTROLLED RELEASE FORMULAS AND TREATMENT OR DISPOSAL PROCEDURES
US7879354B2 (en) * 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
WO2005074976A1 (en) * 2004-02-09 2005-08-18 Transfert Plus Société En Commandite Composition comprising polymeric material and uses thereof
US20050244469A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
US8062652B2 (en) 2004-06-17 2011-11-22 Endo Pharmaceuticals Solutions Inc. Compositions and methods for treating precocious puberty
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
US20060185678A1 (en) * 2005-02-03 2006-08-24 Bronnenkant Lance J Devices for delivering agents to a vaginal tract
US7905181B2 (en) * 2005-02-05 2011-03-15 Ciesiun Paul M Bioluminescent paintball
US7759312B2 (en) * 2005-03-11 2010-07-20 Endo Pharmaceuticals Solutions Inc. Delivery of dry formulations of octreotide
CN101193626A (zh) * 2005-03-11 2008-06-04 益德威士医药股份有限公司 奥曲肽的受控释放制剂
US20060228487A1 (en) * 2005-04-11 2006-10-12 J. Rettenmaier & Söehne GmbH + Co. KG Methods of combining active agents with augmented microcrystalline cellulose
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US20070009573A1 (en) * 2005-07-07 2007-01-11 L N K International Method of forming immediate release dosage form
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US20070178138A1 (en) * 2006-02-01 2007-08-02 Allergan, Inc. Biodegradable non-opthalmic implants and related methods
WO2007093999A1 (en) * 2006-02-15 2007-08-23 Intec Pharma Ltd. A gastro-retentive system for the delivery of macromolecules
JP5457830B2 (ja) * 2006-04-03 2014-04-02 オディディ，イサ オルガノゾル被膜を含む制御放出送達デバイス
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US8802128B2 (en) * 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US20070298073A1 (en) * 2006-06-23 2007-12-27 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
SI2049123T1 (sl) 2006-08-03 2013-04-30 Horizon Pharma Ag Zdravljenje revmatoznih bolezni z zadržanim sproščanjem glukokortikoida
EP1913960A1 (en) * 2006-10-19 2008-04-23 Albert Schömig Coated implant
EP1916006A1 (en) * 2006-10-19 2008-04-30 Albert Schömig Implant coated with a wax or a resin
CA2685397C (en) * 2007-04-27 2016-07-26 Endo Pharmaceuticals Solutions Inc. Implant device release agents and methods of using same
CN101801354A (zh) * 2007-09-17 2010-08-11 麦克内尔-Ppc股份有限公司 含有由聚乙烯醇和聚乙二醇所成的共聚物和树胶的浸涂组合物
US20090196924A1 (en) * 2008-02-04 2009-08-06 Pramod Kharwade Controlled-release lamotrigine formulations
US20090312627A1 (en) * 2008-06-16 2009-12-17 Matott Laura A Radio-labeled ingestible capsule
EP2303226B1 (en) * 2008-06-25 2016-03-23 Endo Pharmaceuticals Solutions Inc. Sustained delivery of exenatide and other polypeptides
CA2729139C (en) 2008-06-25 2016-07-26 Endo Pharmaceuticals Solutions Inc. Octreotide implant having a release agent
AU2009270768A1 (en) * 2008-07-18 2010-01-21 Valeant Pharmaceuticals International Modified release formulation and methods of use
US20100323016A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
US20100323015A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
TWI494108B (zh) * 2009-01-26 2015-08-01 Nitec Pharma Ag 糖皮質激素用以製備嚴重夜間氣喘用之於延遲釋放型的藥物之用途
DK2400950T3 (da) 2009-02-26 2019-07-29 Glaxo Group Ltd Farmaceutiske formuleringer omfattende 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
EP2564836A1 (en) 2009-05-20 2013-03-06 Ranbaxy Laboratories Limited Controlled release lamotrigine formulations
US20110052686A1 (en) 2009-09-03 2011-03-03 Ranbaxy Laboratories Limited Modified release lamotrigine tablets
US8187617B2 (en) * 2009-09-11 2012-05-29 William Wayne Howard Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
EP2515759A4 (en) 2009-12-23 2015-01-21 Given Imaging Inc METHOD OF ASSESSING CONSTIPATION USING INGREDIENT CAPSULE
JP2013517315A (ja) 2010-01-20 2013-05-16 グラクソ グループ リミテッド 新規組成物
USPP22279P2 (en) 2010-09-02 2011-11-29 Floranova Service Corp Ipomoea plant named ‘IPOSGLGRE’
WO2012080833A2 (en) 2010-12-13 2012-06-21 Purdue Pharma L.P. Controlled release dosage forms
US9351924B2 (en) * 2011-03-11 2016-05-31 Snu R&Db Foundation Drug delivery system including laminated structure
PH12014500518A1 (en) * 2011-09-09 2019-10-11 Axxia Pharmaceuticals Llc Silicone coated implants
US20190233345A1 (en) * 2016-03-23 2019-08-01 E. I. Du Pont De Nemours And Company Agricultural systems, compositions and methods for increasing crop yield
TW201828932A (zh) * 2016-11-09 2018-08-16 美商諾沃麥迪斯有限責任公司 1,1-二甲基雙胍之亞硝酸鹽、醫藥組合物及使用方法
CN111386043A (zh) 2017-09-27 2020-07-07 先锋国际良种公司 作物保护剂的土壤施用
CN112955249A (zh) 2018-11-01 2021-06-11 纳幕尔杜邦公司 用于制造农业芯的受控释放的系统和方法
CN113840595A (zh) 2019-05-17 2021-12-24 葛兰素史密斯克莱知识产权发展有限公司 基质组合物，其包含(S)-5-苄基-N-(5-甲基-4-氧代-2,3,4,5-四氢苯并[b][1,4]氧氮杂环庚三烯-3-基)-4H-1,2,4-三唑-3-甲酰胺
US20220175719A1 (en) * 2020-10-24 2022-06-09 Mason Cave Dissolvable thc beverage tablet production method
CN115737580B (zh) * 2022-12-06 2024-04-30 海南皇隆制药股份有限公司 一种提高降血糖效率的伏格列波糖片及其制备方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB972128A (en) * 1960-01-21 1964-10-07 Wellcome Found Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets
GB1022171A (en) * 1961-06-15 1966-03-09 Wellcome Found Prolonged release oral pharmaceutical tablets and their manufacture
FR7805M (es) * 1964-04-09 1970-05-20
NL175029C (nl) * 1970-12-23 1984-09-17 Boehringer Sohn Ingelheim Depotdragee, die bekleed is met een onoplosbare en onverteerbare schaal, die op een of meer plaatsen een uitsparing vertoont.
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
CA1024891A (en) * 1972-06-06 1978-01-24 Boehringer Ingelheim G.M.B.H. Coated retard tablets with exponential release of active ingredient
US4036227A (en) * 1973-04-25 1977-07-19 Alza Corporation Osmotic releasing device having a plurality of release rate patterns
US3924622A (en) * 1973-10-11 1975-12-09 Mead Johnson & Co Zero-order release method
DE2438965A1 (de) * 1974-08-14 1976-02-26 Hoechst Ag Basisch substituierte 3,4-dihydro2h-isochinolin-1-thione und verfahren zu ihrer herstellung
US4135514A (en) * 1974-12-23 1979-01-23 Alza Corporation Osmotic releasing system for administering ophthalmic drug to eye of animal
US3952741A (en) * 1975-01-09 1976-04-27 Bend Research Inc. Controlled release delivery system by an osmotic bursting mechanism
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4058122A (en) * 1976-02-02 1977-11-15 Alza Corporation Osmotic system with laminated wall formed of different materials
US4014334A (en) * 1976-02-02 1977-03-29 Alza Corporation Laminated osmotic system for dispensing beneficial agent
US4111203A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system with means for improving delivery kinetics of system
US4218433A (en) * 1977-03-03 1980-08-19 Nippon Kayaku Kabushiki Kaisha Constant-rate eluting tablet and method of producing same
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4271113A (en) * 1978-04-17 1981-06-02 Alza Corporation Process for forming a passageway in an osmotic device
US4217898A (en) * 1978-10-23 1980-08-19 Alza Corporation System with microporous reservoir having surface for diffusional delivery of agent
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
DE2922522A1 (de) * 1979-06-01 1980-12-04 Dudzik Joachim Tablette
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4519801A (en) * 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
US4610686A (en) * 1983-11-02 1986-09-09 Alza Corporation Controlled delivery of haloperidol by an osmotic delivery system
GB8403138D0 (en) * 1984-02-07 1984-03-14 Graham N B Sustained release of active ingredient
US4601893A (en) * 1984-02-08 1986-07-22 Pfizer Inc. Laminate device for controlled and prolonged release of substances to an ambient environment and method of use
US4772474A (en) * 1985-08-09 1988-09-20 Alza Corporation Dispenser with internal arrangement of lamina means for dispensing beneficial agent
US4693886A (en) * 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom
US4663147A (en) * 1985-09-03 1987-05-05 International Minerals & Chemical Corp. Disc-like sustained release formulation
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US4857330A (en) * 1986-04-17 1989-08-15 Alza Corporation Chlorpheniramine therapy
FR2599624B2 (fr) * 1986-06-09 1990-06-29 Virbac Dispositif a liberation programmee
US4816262A (en) * 1986-08-28 1989-03-28 Universite De Montreal Controlled release tablet
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
US4830860A (en) * 1986-10-30 1989-05-16 Pfizer Inc. Stressed polymeric device for controlled release of a substance to an ambient environment
US4792448A (en) * 1987-06-11 1988-12-20 Pfizer Inc. Generic zero order controlled drug delivery system
US4814183A (en) * 1987-08-31 1989-03-21 Merck & Co., Inc. Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins

Also Published As

Publication number Publication date
GB8820353D0 (en) 1988-09-28
CA1339079C (en) 1997-07-29
IE892736L (en) 1990-02-26
AU4218489A (en) 1990-03-23
ATE110262T1 (de) 1994-09-15
GB2222948B (en) 1993-02-03
GB2222948A (en) 1990-03-28
EP0365123A1 (en) 1990-04-25
DE68917677D1 (de) 1994-09-29
EP0365123B1 (en) 1994-08-24
IE63764B1 (en) 1995-06-14
GB8919448D0 (en) 1989-10-11
DE68917677T2 (de) 1994-12-22
WO1990001925A1 (en) 1990-03-08
US5004614A (en) 1991-04-02

Similar Documents

Publication Publication Date Title
ES2058543T3 (es) Dispositivo de liberacion controlada con un revestimiento impermeable que tiene un orificio para la liberacion de farmaco.
SE8401185D0 (sv) Osmotiskt system med omedelbar lekemedelstillgenglighet
ES2123665T3 (es) Dispositivo para dispensar con membrana soporte de liquido.
ES2139877T3 (es) Agente anti-incrustacion.
ES2128499T3 (es) Cabezal de ducha.
CO5021220A1 (es) Dispositivo de suministro de agentes beneficos y metodo para su elaboracion
ES2167890T3 (es) Sistemas elastomeros de poliurea con adhesion mejorada a sustratos.
ATE260642T1 (de) Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen
PT73886A (fr) Anneau vaginal
ATE391471T1 (de) Stentzuführsystem mit rollmembran
ES2074442T3 (es) Cable de comunicaciones hidrofugo.
NZ502836A (en) Sustained release drug delivery devices
ZA90971B (en) Medicaments having controlled release of the active compound
ES2067944T3 (es) Dispositivo de distribucion de manguito de proteccion.
NO306913B1 (no) Tetningsanordning for avtetning av et ringrom, samt anvendelse av tetningsanordningen
BR7802178A (pt) Agente de diagnostico para a deteccao de hidroperoxidos ou de substancias que reagem com a liberacao de hidroperoxidos ou de peroxidase ou de substancias ativas em peroxidado
ES2175362T3 (es) Agente fitosanitario solido.
ES2176875T3 (es) Sistema de tapon para cerrar los orificios de los elementos de un acumulador y tapa de acumulador para el uso del sistema de tapon.
IT8324279A0 (it) Valvola a sfera con dispositivo dichiusura a tenuta d'emergenza.
IT8167635A0 (it) Sistema di emergenza per ascensori e simili per il salvataggio autonomo dell utente bloccato in cabina
ES503650A0 (es) Procedimiento para la trimetilsililacion de compuestos organicos que llevan uno o mas atomo de hidrogeno activo.
FI891865A7 (fi) Atselastiinia sisältäviä lääkkeitä, joista vaikuttava aine vapautuu säädellysti
ES2027957T3 (es) Un metodo y aparato para la impenetrabilidad del agua y el gas en un cable y/o paso de tubo en una pared o analogo, utilizando una resina sintetica espumable.
IL57227A0 (en) Device for the controlled release of chemicals into an aqueous environment and its manufacture
NO934672L (no) Anordning egnet for intrauterin anvendelse

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 365123

Country of ref document: ES